Involvement of interferon-γ in bowel disease pathogenesis by nitric oxide pathway: A study in algerian patients

Journal of Interferon and Cytokine Research

Volumn 30, Issue 9, 2010, Pages 691-697

  Rafa, Hayet ^a   Amri, Manel ^a   Saoula, Houria ^b   Belkhelfa, Mourad ^a   Medjeber, Osama ^a   Boutaleb, Amira ^b   Aftis, Saida ^b   Nakmouche, M'Hamed ^b   Touil Boukoffa, Chafia ^a  

^a UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^b Bab El Oued Hospital   (Algeria)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADOLESCENT; ADULT; ALGERIA; ARTICLE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; ENTERITIS; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; ALGERIA; ANIMALS; CELLS, CULTURED; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NITRIC OXIDE;

EID: 77956586000     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2010.0012     Document Type: Article

References (45)

1. Andoh A, Yagi Y, Shioya M, Nishida A, Tsujikawa T, Fujiyama Y. 2008. Mucosal cytokine network in inflammatory bowel disease. World J Gastroenterol 14(33):5154-5161.
2. Belenky SN, Robbins RA, Rubinstein I. 1993. Nitric oxide syn-thase inhibitors attenuate human monocyte chemotaxis in vitro. J Leukoc Biol 53:498-503. (Pubitemid 23190035)
3. Claesson MH, Rudolphi A, Kofoed S, Poulsen SS, Reimann J. 1996. CD4\+ T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to an inflammatory and lethal bowel disease. Clin Exp Immunol 104:491-500.
4. Dignass AU, Podolsky DK, Rachmilewitz D. 1995. NOx generation by cultured small intestinal epithelial cells. Dig Sci 40:1859-1865.
5. Drapier JC. 1997. Monoxyde d'azote et macrophages. Pathol Biol 45:110-114.
6. Ebert EC, Panja A, Das KM, Praveen R, Geng X, Rezac C, Bajpai M. 2008. Patients with inflammatory bowel disease may have a transforming growth factor-b, interleukin (IL)-2-or IL-10-deficient state induced by intrinsic neutralizing antibodies. Clin Exp Immunol 155:65-71.
7. Fuss IJ, Neurath M, Boirivant M. 1996. Disparate CD4\+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157:1261-1270.
8. Golab J, Zagozdzon, Stoklosl T, Kaminski R, Kozar K, Jakobisiak M. 2000. Direct stimulation of macrophages by IL-12 and IL-18 a bridge too far? Immunol Lett 72:153-157.
9. Grisham MB, Specian RD, Zimmerman TE. 1994. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J Pharmacol Exp Ther 271:1114-1121.
10. Holub MC, Mako E, Devay T. 1998. Increased interleukin-6 levels, interleukin-6 receptor and gp130 expression in peripheral lymphocytes of patients with inflammatory bowel disease. Scand J Gastroenterol 228 (Suppl.):47-50.
11. Huang FP, Niedbala W, Wei XQ. 1998. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur J Immunol 28:4062-4070.
12. Karlinger K, Gyorke T, Mako E, Mester A, Tarjan Z. 2000. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 35:154-167.
13. Kimura H, Miura S, Shigematsu T, Ohkubo N, Tsuzuki Y, Kurose I, Higuchii H, Akiba Y, Hokari R, Hirokawam M, Serizawa H, Ishii H. 1997. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig Dis Sci 42:1047-1054.
14. Kirsner JB, Shorter RG. 1988. Inflammatory bowel disease, 3rd ed. Philadelphia: Lea & Febiger.
15. Knowles RG, Moncada S. 1994. Nitric oxide synthases in mammals. Biochem J 289:249-258.
16. Kolios G, Rooney N, Murphy CT, Robertson DAF, Westwick J. 1998. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut 43:56-63.
17. Kolios G, Valatas V, Ward SG. 2004. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved pizzle. Immunology 113:427-437.
18. Kolios G, Wright K, Linehan JD, Robertson DA, Westwick J. 2000. Interleukin-13 inhibits nitric oxide production in human colonic mucosa. Hepatogastroenterology 47:714-717.
19. Kubin M, Chow J M, Trinchieri G. 1994a. Differential regulation of interleukin-12 (IL-12), tumor necrosis factor alpha, and IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 83: 1847-1855.
20. Kubin M, Kamoun M, Trinchieri G. 1994b. Interleukin 12 sy-nergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med 180:211-222.
21. Kugathasan S, Saubermann LJ, Smith L, Kou D, Itoh J, Binion DG, Levine AD, Blumberg RS, Fiocchi C. 2007. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Gut 56:1696-1705.
22. Linchan JD, Kolios G, Valatas V, Robertson AF, Westwick J. 2005. Immunomodulatory cytokines suppress epithelial nitric oxide production in inflammatory bowel disease by acting on mononuclear cells. Free Radic Biol Med 39:1560-1569.
23. Mazlam MZ, Hodgson HJF. 1992. Peripheral blood monocytes production and acute phase response in inflammatory bowel disease. Gut 33:773-778.
24. Mckenzie ANJ, Culpepper JA, De Waal Malefyt R. 1993. Inter-leukin-13, a T-cell derived cytokine that regulates human monocytes and B-cell function. Proc Natl Acad Sci USA 90:3735-3739.
25. Middleton SJ, Shorthouse M, Hunter JO. 1993. Increased nitric oxide synthesis in ulcerative colitis. Lancet 341:465-466.
26. Moncada S, Higgs A. 1993. The l-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012.
27. Monteleone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza F, Pallone F. 1997. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 112:1169-1178.
28. Monteleone G, Parrello T, Luzza F, Pallone F. 1998. Response of human intestinal lamina propria T lymphocytes to inter-leukin 12: additive effects of interleukin 15 and 7. Gut 43: 620-630.
29. Mudter J, Neurath MF. 2007. IL-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis 13:1016-1023.
30. Murakami H, Akbar SM, Matsui H. 2001. Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest 31:337-343.
31. Nathan C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064.
32. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W. 1994. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182:1281-1290.
33. Niessner M, Volk BA. 1995. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 101:428-435.
34. Podlaski FJ, Nanduri VB, Hulmes JD, Pan Y-CE, Levin W, Danho W, Chizzonite R, Gately MK, Stem AS. 1992. Molecular characterization of interleukin 12. Arch Biochem Bio-phys 294:230-237.
35. Podolsky DK. 2002. The current future understanding of inflammatory bowel disease. Best Pract Res Clin Gastroenterol 16:933-943.
36. Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, Coffman RL. 1994. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45 RBhi CD4+T cells. Immunity 1:553-562.
37. Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK. 1995. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 36:718-723.
38. Reynolds PD, Middleton SJ, Hunter JO, Facer P, Bishop A, Evans T, Polak JM. 1995. High expression of iNOS in colonic mucosa in ulcerative colitis. Gastroenterology 108:A903-A909.
39. Rezaie A, Khalaj S, Shabihkhani M, Nikfar S, Zamani MJ, Mohammadirad A, Daryani NE, Abdollahi M. 2007. Study on the correlations among disease activity index and salivary transforming growth factor-b1 and nitric oxide in ulcerative colitis patients. Ann N Y Acad Sci 1095:304-314.
40. Rogler G. 2004. Update in inflammatory bowel disease patho-genesis. Curr Opin Gastroenterol 20:311-317. (Pubitemid 38813671)
41. Sartor RB. 1994. Cytokines in intestinal inflammation: patho-physiological and clinical considerations. Gastroenterology 106:533-539.
42. Singer LL, Kawka DW, Scott S, Weidner JR, Numfordra Riehl TE, Stenson WF. 1996. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in IBD. Gastroenterology 10:151-164.
43. Tepperman BL, Brown JF, Whittle BJR. 1993. Nitric oxide syn-thase induction and intestinal epithelial cell viability in rats. Am J Physiol 265:G214-G218.
44. Touil-Boukoffa C, Bauvois B, Sanceau J, Hamrioui B, Wietzerbin J. 1998. Production of nitric oxide (NO) in human hydatidosis. Relationship between nitrite and IFN-g levels. Biochimie 80:739-744.
45. Yoshida A, Koide Y, Uchijima M, Yoshida TO. 1994. IFN-gamma induces IL-12 mRNA expression by a murine macrophages cell line, J774. Biochem Biophys Res Commun 198:857-861.